MBP and chronic myelogenous leukemia, BCR-ABL1 positive: With an increased understanding of the molecular mechanisms that drive CML-MBP transformation, including hypermethylation of several significant oncogenes, an emphasis on epigenetic reprogramming may be associated with improved outcomes compared to more intensive chemotherapy.